Analysis

Chewy (CHWY): Three factors that work in favor of this pet retailer

Shares of Chewy, Inc. (NYSE: CHWY) gained over 1% on Monday. The stock has dropped 10% in the past three months. The

Earnings Preview: Will cost pressures impact Darden Restaurants’ Q2 results?

Darden Restaurants, Inc. (NYSE: DRI), a full-service restaurant operator, has faced margin pressure this year from higher input costs tied to tariffs

NKE Q2 Earnings Preview: Can Nike maintain the recovery momentum?

Sneaker giant NIKE, Inc. (NYSE: NKE) entered the fiscal year facing heightened competition and shifting consumer preferences. Its upcoming second-quarter results are

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

NKE Q2 Earnings Preview: Can Nike maintain the recovery momentum?

Sneaker giant NIKE, Inc. (NYSE: NKE) entered the fiscal year facing heightened competition and shifting consumer preferences. Its upcoming second-quarter results are expected to reflect these evolving industry dynamics and

December 12, 2025

Earnings Preview: Conagra Brands’ (CAG) sales and earnings projected to decline in Q2 2026

Shares of Conagra Brands, Inc. (NYSE: CAG) rose 1% on Friday. The stock has dropped 7% in the past three months. The branded food company is slated to report its

December 12, 2025

Costco (COST) reports strong growth in Q1 FY26 earnings; revenue up 8%

Costco Wholesale Corporation (NASDAQ: COST) has reported an increase in net income for the first quarter of fiscal 2026. Revenues grew 8.3% year-over-year. The Issaquah, Washington-headquartered warehouse giant’s total revenues

December 12, 2025

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top